Original Research

Value For Money In The Treatment Of Patients With Type 2 Diabetes Mellitus: Assessing The Long-Term Cost-Effectiveness Of IDegLira Versus iGlarLixi In Italy

Pöhlmann J, Montagnoli R, Lastoria G, Parekh W, Markert M, Hunt B

ClinicoEconomics and Outcomes Research 2019, 11:605-614

Published Date: 7 October 2019